Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $601.32 Analyst target: $670.93 Upside: 11.58%
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.